Published on 21 Jul 2021 on GoBankingRates via AOL
Moderna Enters the S&P Amid Delta Variant Fears – Should You Invest?
Moderna entered the S&P 500 today, amid increasing global fears around the Delta variant. The stock...
Bayer's (BAYRY) Parkinson's Disease Therapy Gets Fast Track Tag
Bayer Aktiengesellschaft’s BAYRY wholly owned subsidiary, BlueRock Therapeutics LP, announced tha...
Alexion Pharmaceuticals (ALXN) Earnings Expected to Grow: Should You Buy?
The market expects Alexion Pharmaceuticals (ALXN) to deliver a year-over-year increase in earning...
ALXN vs. TECH: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably al...
Moderna Enters the S&P Amid Delta Variant Fears – Should You Invest?
Moderna entered the S&P 500 today, amid increasing global fears around the Delta variant. The sto...
Moderna stock 'has taken on a life of its own,' jumps 4% in S&P debut
Moderna (MRNA) began trading on the S&P 500 on Wednesday, replacing Alexion Pharmaceuticals Inc. ...
Moderna being added to S&P 500
The biotech company, which has already delivered over 100 million COVID-19 vaccines, will replace...
Alexion Pharmaceuticals Inc. stock outperforms market on strong trading day
Shares of Alexion Pharmaceuticals Inc. advanced 1.70% to $182.50 Tuesday, on what proved to be an...
Alexion (ALXN) Reports Positive Data on Ultomiris From gMG Study
Alexion Pharmaceuticals, Inc. ALXN announced that the late-stage study evaluating its long-acting...
Moderna to join S&P 500, shares jump after hours
Moderna Inc (MRNA.O) will join the S&P 500 index (.SPX) as of the start of trading on July 21, re...
Moderna Climbs as S&P 500 Set to Welcome Covid Vaccine Maker
The company, whose messenger-RNA vaccine has helped to fight the Covid-19 pandemic, will replace ...